Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

iShares Nasdaq Biotechnology ETF (IBB)

Delayed Data
As of Sep 30
 +3.59 / +1.26%
Today’s Change
Today|||52-Week Range
IBB Regular Dividend: IBB began trading ex-dividend on 09/26/16. A $0.0858 dividend will be paid to shareholders of record as of 09/28/16.

Investment Objective

The investment seeks to track the investment results of the NASDAQ Biotechnology Index, which contains securities of NASDAQ  listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by Nasdaq, Inc. The fund generally invests at least 90% of its assets in securities of the index and in depositary receipts representing securities of the index. It may invest the remainder of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.

Buy These 4 Stocks and Beat Biotech's Slump
Sep 30 / TheStreet.com - Paid Partner Content
The Zacks Analyst Blog Highlights: iShares Gold ETF, VanEck Vectors Coal ETF, Raytheo...
Sep 26 / Zacks.com - Paid Partner Content
Clinton Apparently Won First Debate: ETFs in Focus
Sep 27 / Zacks.com - Paid Partner Content
Prepare for a Trump Presidency With These Stocks & ETFs
Sep 23 / Zacks.com - Paid Partner Content
Biotech ETFs May Be a Prescription for Investment Success, Especially If Trump Become...
Sep 26 / TheStreet.com - Paid Partner Content
ETFs in Focus on the Nasdaq Rally
Sep 23 / Zacks.com - Paid Partner Content


1 month+3.03% 3 years+11.48%
3 months+12.41% 5 years+25.62%
1 year-4.29% Since inception+7.17%
Data through 10/01/2016

Quote Details

Previous close$285.87
Open day’s range283.72 – 290.53
Net asset value (NAV)289.35 (09/30/2016)
Daily volume2,138,141
Average volume (3 months)1,535,816
Data as of 4:14pm ET, 09/30/2016

Peer Comparisonvs. Health ETFs

Performance 5-yr return+25.62%+15.32%
Expense Gross exp ratio0.47%0.48%
Risk 5 year sharpe ratio1.101.16
Net assets$7.3B$1.1B
Average market cap$16.0B$37.2B
Average P/E20.120.2
Dividend / Share--0.22%


XLV Health Care Select Sector SPDR® Fund
RYH Guggenheim S&P 500® Equal Weight Health...
VHT Vanguard Health Care Index Fund ETF Shar...


Top 5 Sectors
Portfolio weighting
Healthcare 99.91%
Business service 0.09%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
AMGN Amgen8.49%
BIIB Biogen8.32%
CELG Celgene7.97%
GILD Gilead Sciences7.10%
REGN Regeneron Pharmaceuticals7.01%
ILMN Illumina Inc4.46%
VRTX Vertex Pharmaceuticals Inc4.00%
MYL Mylan NV3.85%
ALXN Alexion Pharmaceuticals Inc3.29%
SHPG Shire2.98%

Search for Jobs